Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Water Vapor Thermal Ablation System for the Treatment of Benign Prostatic Hyperplasia

NCT06725212 is registered in ClinicalTrials.gov with Medtecx Co Ltd. as lead sponsor.

NCT NCT06725212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06725212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Water Vapor Thermal Ablation System for the Treatment of Benign Prostatic Hyperplasia
Lead sponsor
Medtecx Co Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
March 26, 2024
Completion date
June 1, 2026
Enrollment
126 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia